Publish in this journal
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients
Ampliación del estudio RENACER: eficacia, seguridad y supervivencia a 12 meses de 501 pacientes de artritis reumatoide tratados con Certolizumab PEGol
Vicenç Torrente-Segarraa,
Corresponding author
, Manuel Fernández Pradab, Rosa Expósitoc, Noemí Patricia Garrido Puñald, Amalia Sánchez-Andradee, José Ramón Lamúa-Riazuelof, Alejandro Olivég, Juan Víctor Tovarh, on behalf of RENACER Study Group
a Hospital Comarcal Alt Penedès, Spain
b Hospital Universitario de Guadalajara, Spain
c Hospital Comarcal de Laredo, Spain
d Hospital Universitario Virgen del Rocío, Spain
e Complejo Hospital Universitario Lucus Augusti, Spain
f Hospital Universitario del Henares, Spain
g Hospital Germans Tries i Pujol, Spain
h Hospital General Universitario de Elche, Spain
Read
287
Times
was read the article
132
Total PDF
104
Total HTML
51
Total EPUB
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2021 October 29 35 9 73
2021 September 27 38 14 79
2021 August 22 27 11 60
2021 July 26 32 17 75
2021 June 0 0 0 0
2021 May 0 0 0 0
2021 April 0 0 0 0
2021 March 0 0 0 0
2021 February 0 0 0 0
2021 January 0 0 0 0

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?